BACKGROUND: Fatigue was recently suggested to predict an increased risk of mortality in a primary biliary cirrhosis (PBC) cohort during follow-up. AIMS: To analyse the impact of fatigue on prognosis in PBC. METHODS: Patients with PBC who had earlier completed the fatigue impact scale (FIS) were identified. Prognosis in terms of death and liver transplantation (Tx) was determined. RESULTS: FIS values at baseline were analysed from 208 patients (192 females; median age 59 years (interquartile range 51-67), median follow-up of 5 years. Overall, 181 patients were alive at follow-up, 22 (12%) died and five (2.4%) underwent transplantation. FIS at baseline was 28 (12-47) and FIS at follow-up was 25 (8-64) (P<0.001; r=0.69). Among survivors, FIS at baseline was 27 (12-43), 36 (12-72) in those who died (P=0.059) and 99 (41-102) in those who underwent transplantation (P=0.0008). FIS at baseline was 44 (12-88) in patients with death and/or Tx vs. 27 (12-43) in survivors (P=0.003). Age [hazard ratio (HR) 1.1 (confidence interval (CI) 1.0-1.2)] and aspartate aminotransferase [HR 2.0 (CI 1.3-3.0)] were independently associated with decreased survival on multivariate analysis. FIS scores over 40 [HR 9.6 (CI 2.3-39.7)] and bilirubin [HR 4.8 (CI 2.8-8.2)] were independently associated with a poor outcome in patients who underwent Tx or had a liver-related death. CONCLUSIONS: Fatigue seems to change little over time in PBC. Fatigue levels were higher at baseline in those who died or underwent Tx. High fatigue levels seem to be a predictor of risk of liver-related mortality and need for transplantation over time but not a predictor of non-liver-related mortality.
BACKGROUND:Fatigue was recently suggested to predict an increased risk of mortality in a primary biliary cirrhosis (PBC) cohort during follow-up. AIMS: To analyse the impact of fatigue on prognosis in PBC. METHODS:Patients with PBC who had earlier completed the fatigue impact scale (FIS) were identified. Prognosis in terms of death and liver transplantation (Tx) was determined. RESULTS: FIS values at baseline were analysed from 208 patients (192 females; median age 59 years (interquartile range 51-67), median follow-up of 5 years. Overall, 181 patients were alive at follow-up, 22 (12%) died and five (2.4%) underwent transplantation. FIS at baseline was 28 (12-47) and FIS at follow-up was 25 (8-64) (P<0.001; r=0.69). Among survivors, FIS at baseline was 27 (12-43), 36 (12-72) in those who died (P=0.059) and 99 (41-102) in those who underwent transplantation (P=0.0008). FIS at baseline was 44 (12-88) in patients with death and/or Tx vs. 27 (12-43) in survivors (P=0.003). Age [hazard ratio (HR) 1.1 (confidence interval (CI) 1.0-1.2)] and aspartate aminotransferase [HR 2.0 (CI 1.3-3.0)] were independently associated with decreased survival on multivariate analysis. FIS scores over 40 [HR 9.6 (CI 2.3-39.7)] and bilirubin [HR 4.8 (CI 2.8-8.2)] were independently associated with a poor outcome in patients who underwent Tx or had a liver-related death. CONCLUSIONS:Fatigue seems to change little over time in PBC. Fatigue levels were higher at baseline in those who died or underwent Tx. High fatigue levels seem to be a predictor of risk of liver-related mortality and need for transplantation over time but not a predictor of non-liver-related mortality.
Authors: Victoria A L Mosher; Mark G Swain; Jack X Q Pang; Gilaad G Kaplan; Keith A Sharkey; Glenda M MacQueen; Bradley G Goodyear Journal: Clin Transl Gastroenterol Date: 2017-07-27 Impact factor: 4.488
Authors: Victoria Mosher; Mark Swain; Jack Pang; Gilaad Kaplan; Keith Sharkey; Glenda MacQueen; Bradley Gordon Goodyear Journal: PLoS One Date: 2019-02-08 Impact factor: 3.240
Authors: Lorenzo Montali; Andrea Gragnano; Massimo Miglioretti; Alessandra Frigerio; Luca Vecchio; Alessio Gerussi; Laura Cristoferi; Vincenzo Ronca; Daphne D'Amato; Sarah Elizabeth O'Donnell; Clara Mancuso; Martina Lucà; Minami Yagi; Anna Reig; Laura Jopson; Sesé Pilar; Dave Jones; Albert Pares; George Mells; Atsushi Tanaka; Marco Carbone; Pietro Invernizzi Journal: J Transl Autoimmun Date: 2021-01-06